Company / Financials
Apyx Medical Corp Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$52.8M
FY2025 · +9.9% YoY
Net Income
-$11.2M
FY2025 · +52.2% YoY
Profit Margin
-21.2%
FY2025 · net income / revenue
ROE
-77.1%
FY2025 · return on equity
Total Assets
$66.8M
FY2025
Total Debt
$37.5M
2.58x debt/equity
Equity
$14.5M
FY2025
ROA
-16.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$52.8M+9.9% YoYNet Income HistoryProfit after all expenses and taxes-$11.2M+52.2% YoYGross Profit HistoryRevenue minus cost of goods sold$33.0M+12.5% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$19.8M+5.6% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$6.4M+65.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$15.8M-16.2% YoYR&D Expense HistoryResearch and development spending$3.4M-33.6% YoYInterest Expense HistoryCost of borrowing and debt obligations$15.0KIncome Tax HistoryTotal income tax expense$270.0K+7.1% YoYEPS (Basic) HistoryBasic earnings per share-$0.66-22.2% YoY